The number of Brazilians with a complete vaccine scheme with two doses or with the immunizing agent of a single application against covid-19 reaches 98.831,064 this Saturday, 9. 968,839 applications were registered in the last 24 hours. With vaccination continuing in Brazil, 149.5 million people are partially immunized, that is, they received at least one dose. In relation to the total population, this number is equivalent to 70.07%.
The first doses were applied to 299 thousand people. On the other hand, there were 571,209 with the 2nd application of the vaccine. Single-dose immunizers were given to 1,320 people. The booster doses were administered in 97,221. The data are from the consortium of press vehicles, in partnership with 27 Health secretariats.
The Minister of Health, Marcelo Queiroga, announced at a press conference on Friday, 8th, that Brazil has 354 million doses against covid-19 “acquired or in advanced treatments” to be used in the 2022 immunization campaign. the news, the federal government also stated that it intends to administer only one dose to the public aged 18 to 60 years in the next vaccination cycle. For elderly and immunosuppressed, vaccination will be with two doses.
Read Also
- What does “The social media dilemma” count, the Netflix documentary that exposes the darker side of our digital addiction Sep 18, 2020
- Friends, Giulia Stabile’s appeal: “Do not disclose that photo” Aug 20, 2021
- Seine-et-Marne: The Center Parcs Villages Nature would be infested with rats Nov 21, 2022
- Space, Avio lands at the Italian Pavilion of Expo Dubai Jul 14, 2021
- La Voz Senior Perú 2021 LIVE premiere on Internet TV Frequency: follow the blind auditions, judges, what time it opens, channel Aug 28, 2021
- New update brings voice chats and more Dec 23, 2020
- What technology is used to practice a job interview May 29, 2022
This year, with the exception of people who received the immunizing Janssen, a single dose, the Ministry of Health campaign was planned to apply at least two doses in all age groups covered, including teenagers. For specific audiences, such as the elderly and the immunosuppressed, an additional dose was also administered, which in principle is not planned for next year.